Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue.

Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue.
复制标题

DOI:
10.3164/jcbn.12-95
复制
发表时间:
2013-03
影响因子:
2.4
通讯作者:
Sakamoto C
Sakamoto C
中科院分区:
医学4区
文献类型:
--
作者:
Song J;Futagami S;Nagoya H;Kawagoe T;Yamawaki H;Kodaka Y;Tatsuguchi A;Gudis K;Wakabayashi T;Yonezawa M;Shimpuku M;Watarai Y;Iwakiri K;Hoshihara Y;Makino H;Miyashita M;Tsuchiya S;Li Y;E Crowe S;Sakamoto C

文献摘要

参考文献

被引文献

相似文献

Apurinic/apyrimidinic endonuclease-1 (APE-1), a key enzyme responsible for DNA base excision repair (BER), has been linked to cancer chemoradiosensitivity. The phosphorylation of p65 plays a role in the activation of this pathway. In this study, we investigated APE-1 expression and its interaction with p65 in esophageal squamous cell carcinoma (ESCC) tissue. The expression of APE-1, p65, p65 nuclear localization sequence (p65-NLS), and monocyte chemoattractant protein-1 (MCP-1) was assessed by immunohistochemical analysis in 67 human ESCC tissue samples. Real-time PCR and western blotting were also performed. p65 siRNA was evaluated to determine the role of p65 in the regulation of APE-1 expression. We found nuclear localization of APE-1 in 89.6% (60/67) of ESCC tissue samples. We also observed the colocalization of p65-NLS and APE-1 in esophageal cancer tissue. In KYSE220 cells, pretreatment of MG-132 significantly abrogated upregulation of p65 and APE-1 levels induced by MCP-1, and treatment with 10 and 20 nM p65 siRNA significantly inhibited APE-1 mRNA expression. siRNA for p65 treatment significantly increased the apoptotic index in 5-FU-treated KYSE220 cells. We conclude that APE-1 is overexpressed and mainly localized in the nuclear compartment of cancer cells, and partly regulated by p65 in the NF-κB pathway in ESCC tissue.
DOI: 10.1038/sj.bjc.6605120
发表时间: 2009-07-07
影响因子: 8.8
作者:
通讯作者: --
DOI: 10.1016/j.lungcan.2009.02.019
发表时间: 2009-12-01
期刊: LUNG CANCER
影响因子: 5.3
作者:
Wang, Dong;Xiang, De-Bing;Zhang, Yun-Song
通讯作者: Zhang, Yun-Song
DOI: 10.1556/oh.2009.28558
发表时间: 2009-03-01
期刊: Orvosi Hetilap
影响因子: 0.6
作者:
Hagymasi Krisztina;Tulassay Zsolt
通讯作者: Tulassay Zsolt
DOI: 10.1016/j.surg.2010.05.002
发表时间: 2010-08-01
期刊: SURGERY
影响因子: 3.8
作者:
Lazar, Melissa;Sullivan, Jennifer;Arafat, Hwyda A.
通讯作者: Arafat, Hwyda A.
DOI: 10.1002/ijc.10705
发表时间: 2002-11-20
影响因子: 6.4
作者:
Ohta, M;Kitadai, Y;Chayama, K
通讯作者: Chayama, K